IL-2 for Multi Drug Resistant Nephrotic Syndrome

NCT02455908 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Istituto Giannina Gaslini